A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole

• Main Authors: Mohsin Hamid (Author), Bilal Lashari (Author), Irfan Ahsan (Author), Ida Micaily (Author), Usman Sarwar (Author), Joseph Crocetti (Author)
• Format: Book
• Published: Greater Baltimore Medical Center, 2018-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Methotrexate (MTX) is a chemotherapeutic synthetic(s) phase cell cycle inhibitor, and its role has evolved as an immunological agent in autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, etc. Trimethoprim-sulfamethoxazole (TS) is one of the most widely prescr...